### **Company Overview** India Glycols Limited (IGL), established in **1983**, is a leading Indian manufacturer and innovator in **bio-based specialties, performance chemicals, potable spirits, biofuels, plant-based APIs, and nutraceuticals**. Headquartered in Kashipur, Uttarakhand, IGL operates three integrated manufacturing facilities in **Kashipur, Gorakhpur, and Dehradun**, spread across approximately **360 acres**, and exports to **over 40 countries**. The company has evolved from a glycols producer to a diversified, sustainability-driven enterprise, positioning itself at the forefront of green chemistry, circular economy initiatives, and value-added product innovation. --- ### **Business Segments & Revenue Split (FY25 Estimate)** As of November 2025, IGL’s business is structured into four core segments: 1. **Potable Spirits (71.19%) – ₹6,434 crores** - Leading player in **branded country liquor** in **Uttar Pradesh and Uttarakhand**. - Core brands: *Amazing Vodka*, *Soulmate Blu Whisky*, *Zumba Lemoni Rum*, *Bunty Bubli* (three-time highest-selling liquor brand). - Also launched **cranberry-flavored vodka** and introduced **IGL Zumba Lemoni™**, a citrus rum. - Supply licenses in key states and presence in **paramilitary** (CSD) and **institutional channels**. 2. **Bio-Based Specialities & Performance Chemicals (14.84%) – ₹1,341 crores** - Flagship products: **Bio-Monoethylene Glycol (Bio-MEG)**, glycol ethers, bio-polymers, industrial gases, green solvents. - Produces **100% of India’s commercial bio-based MEG** – used in PET for sustainable packaging and textiles. - Unique capability: **Only Indian plant producing both Ethylene Oxide (EO) and Liquid CO₂** for medical sterilization gas (*IGL-STERI GAS*). - Key target sectors: oil & gas, automotive, personal care, pharma, textiles, industrial cleaning. 3. **Biofuels / Power Alcohol (11.55%) – ₹1,044 crores** - Supplies **grain-based ethanol** to **Oil Marketing Companies (OMCs)** under the **Ethanol Blending Programme (EBP)**. - Distillery capacities: **500 KLPD (Kashipur)** and **310 KLPD (Gorakhpur)**. - Expansion underway at Gorakhpur to **190 KLPD biofuel capacity** (expected Q1 FY26). 4. **Ennature Biopharma (2.42%) – ₹219 crores** - Focus: **Plant-based APIs, nutraceuticals, phytochemicals, and health supplements**. - Key products: **Thiocolchicoside** (global leadership), **nicotine & nicotine salts**, **Maxicuma®**, **Xanthogreen™**. - Supplies **pure nicotine** to international NRT (nicotine replacement therapy) manufacturers. --- ### **Key Strategic Developments (Q4 2025)** #### 1. **Sustained Growth in Potable Spirits & Partnerships** - IGL secured rights to distribute its in-house spirits brands — **Zumba Lemoni**, **Soulmate Blu**, and **Amazing Vodka** — in **Kerala**, a high-potential market. Plans are underway to launch an **in-house Brandy**. - Continues to co-pack **Bacardi’s portfolio** (including **Breezer**, **Carta Blanca**) at its Kashipur unit under a full-service arrangement (distillation, maturation, logistics). - Strategic partnership with **Amrut Distilleries** enables IGL to **manufacture, bottle, market, and sell** premium Amrut brands (e.g., **Maqintosh White & Black Label**, **Bejois XO**) in **North India** on a royalty basis. - Maqintosh launched in **Delhi-NCR** in July 2024; achieved **>10% market share** within months. - **Paramilitary segment:** Now supplies five IMFL brands across 19 states and ranks among **top four suppliers** via centralized procurement. - Plans to enter the **Canteen Stores Department (CSD)** with **Soulmate Whisky** and **Zumba Limon**, targeting long-term defense force demand. #### 2. **Innovation & Expansion in Specialty Chemicals** - Became the **first company globally to commercialize bio-based amines**, including **Bio-Monoethanolamine** for cosmetics, in collaboration with **L’Oreal**. - Collaborating with **Scientific Design Inc. (US)** for **bio-glycols**, **LanzaTech** for **C-Smart® alcohol**-based specialty chemicals, and **Clariant** (JV) for **bio-ethoxylates**. - Uses **Sulzer Chemtech’s continuous process** for glycol ethers — **only Indian manufacturer** with this technology. - Launched **"iGreen" solvent platform** (bio-esters, bio-ether esters) for agricultural and personal care applications. - Developing a pipeline of **over 30 new green molecules**, including: - Bio-polymers (from guar/polygalactomannans) - Specialty bio-amines - Carbon-smart (C-Smart) derivatives - Green plasticizers - APIs and nutraceuticals #### 3. **Ennature Biopharma: Strengthening Branded & Regulated Portfolios** - Projected **FY25 EBITDA of ₹525 crores**, with net profit of **₹231 crores**, reflecting strong underlying performance. - Facing **export headwinds** due to **declining nicotine demand** (Europe, Turkey) and **seed shortages**, but pivoting toward: - **Clinical validation & claim substantiation** of nutraceuticals. - **Branded ingredient strategy** in **US and EU markets** (e.g., **Maxicuma® – nanotized curcumin**). - **Regulatory filings** in USFDA and EU to support direct market access. - Maintains **germplasm bank** for over **100 herb species** (artemisia, stevia, marigold) with **contract farming agreements**. - Aims to **launch branded nutraceuticals directly in US/Europe**, potentially improving margins significantly. #### 4. **Biofuels & Green Energy Momentum** - Now actively supplying **bio-ethanol from grain-based distilleries** to OMCs — entering a new revenue stream. - Government **ethanol blending target of 20% by 2025** creates sustained tailwinds. - Flexible ethanol sourcing: dynamically allocates self-produced **grain/molasses-based ENA** across **spirits, chemical intermediates, and biofuels** based on profitability. - Exploring **Sustainable Aviation Fuel (SAF)** as a future growth area — though in “wait and watch” mode due to regulatory uncertainty. #### 5. **Sustainability & Circular Economy Leadership** - A global pioneer in **carbon-captured chemistry**: uses **ethanol from recycled industrial emissions** (via LanzaTech) to produce **MEG and derivatives**. - Achieves **near-zero liquid/solid discharge** via **supercritical CO₂ extraction** and **closed-loop biomass energy systems**. - Only Indian company producing **Medical Grade STERI-GAS** (EO + CO₂ mixture) under **ISO 13485:2016 certification**. - Sold **1,796 MT** of STERI Gas in FY25 — **25% YoY growth** from 1,431 MT. --- ### **Corporate Strategy & Business Model** - **Modular expansion model** allows for **incremental CAPEX** and **scalable capacity additions** based on demand. - **Restructuring into three independent business verticals**: 1. **Chemicals**: Green/specialty chemicals, bio-glycols, industrial gases 2. **Spirits**: IMFL, country liquor, bio-alcohol 3. **Ennature Biopharma**: APIs, nutraceuticals, phytochemicals - This facilitates targeted investments and value unlocking. #### Strategic Focus Areas: - **Premiumization**: Launching higher-value spirits and expanding in defense/paramilitary channels. - **Export-led growth**: Focus on **regulatory-compliant, science-backed nutraceuticals and green chemicals** in North America, Europe, Far East. - **Green differentiation**: Marketing **Bio-MEG**, **bio-glycols**, and **carbon-smart chemicals** as low-carbon alternatives. - **Customer-driven innovation**: 60–70% of new specialty chemicals developed through **long-term customer collaboration** (e.g., with **Unilever, Lululemon, Migros**). --- ### **Global Recognition & Competitive Strengths** - **Three-Star Export House** (Government of India). - Supplies **global multinationals** including **Coca-Cola**, **Bacardi**, **Unilever**, **Diageo**, **Pernod Ricard**, **Reliance**, and **HUL**. - Strong R&D infrastructure: - DSIR-recognized labs in **Dehradun & Kashipur** - **Pilot plants**, **plug-flow reactors**, **bio-solvent and bio-amine R&D** - **Nanotechnology platforms** (Maxicuma®, SCEMOD™, LIMAN™) - **Proprietary technology stack** spanning **bio-ethylene**, **carbon capture**, and **green extraction**. --- ### **Challenges & Risks** - **Commoditization risk** in APIs (Thiocolchicoside, nicotine) due to competition and price pressure from new entrants. - **Volatility in glycol ether markets** due to **low-cost Chinese/Russian imports**. - **Guar gum market dependence** on crude oil prices and fracking activity in the US. - **Regulatory uncertainty** in state excise policies (e.g., Delhi, UP).